A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Eli Lilly and Company
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Pfizer
Toray Industries, Inc
Trishula Therapeutics, Inc.
IGM Biosciences, Inc.
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Canadian Cancer Trials Group
Eli Lilly and Company
Gilead Sciences
TG Therapeutics, Inc.
Masonic Cancer Center, University of Minnesota
Northwestern University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)